Leukopenia, a Complication of Chloromycetin Therapy of Chronic Discoid Lupus Erythematosus  by Robinson, Harry M. et al.
LEUKOPENIA, A COMPLICATION OF CHLOROMYCETIN
THERAPY OF CHRONIC DISCOID LUPUS
ERYTHEMATOSUS *
HARRY M. ROBINSON, JR., M.D., ISRAEL ZELIGMAN, M.D., ALBERT
SHAPIRO, M.D., AND MORRIS M. COHEN, M.D.
Chioromycetin has recently been administered in the treatment of different
types of lupus erythematosus. H. M. Robinson, Sr. (1) treated thirteen patients
with the chronic discoid type; of these, five completely cleared, six improved,
one showed no improvement, and one developed acute disseminated lupus
erythematosus. Johnson, et al., (2) treated three cases of systemic lupus erythem-
atosus without benefit. Hopkins (3) presented a case of subacute disseminated
lupus erythematosus who had been treated with chloromycetin; the patient's
temperature was normal thirteen days following the institution of treatment
and the eruption faded. Cormia (4) stated that he had studied a patient with
subacute lupus erythematosus who had been aggravated by chlorampheaicol.
We have recently been studying the effects of chloromycetin therapy on many
dermatoses, and in the course of our investigation have treated fourteen pa-
tients who had chronic discoid lupus erythematosus. We have noted the appear-
ance of leukopenia as a complication of therapy in four of these individuals.
Blood counts were performed at periodic intervals prior to and following the
institution of therapy. All the patients hut one received an initial dose of two
grams of chloromycetin, followed by 0.5 grams four times daily. The remaining
patient received a dose of one gram, followed by 0.5 grams, every six hours.
The following are case reports of the four patients who developed leukopenia
while under treatment for chronic discoid lupus erythematosus with chloromy-
cetin.
CASE REPORTS
Case 1: H. H., a 38 year old white female was first seen at the Skin Clinic of the Uni-
versity Hospital on June 7, 1950. A clinical diagnosis of chronic lupus erythematosus was
made and confirmed by biopsy. No improvement was observed following therapy with
injections of bismuth subsalicylate. Examination on January 4, 1951 disclosed an cry-
thematous plaque measuring 1.5 cm. in diameter on the right cheek. Several similar but
smaller lesions were present on both cheeks. The blood count was as follows: hemoglobin
14.3 grams—99%, red blood cells 4,850,000, white blood cells, 5,700 with a normal dif-
ferential count.
Treatment with chloromycetin was begun on January 4, 1951 with an initial dose of 2
grams, followed by doses of 0.5 gm. every 6 hours. By January 26th, some decrease in
erythema was noted in some of the smaller lesions. On February 3rd, the hemogram was
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normal, but on February 25th, the white blood cell count had decreased to 3,000 with a
normal differential count. Chloromycetin was discontinued. Blood counts were taken at
frequent intervals and showed a gradual return to normal. On May 14, 1951 the leukocyte
count was 7,300 and the differential count normal. There were no symptoms associated with
the leukopenia.
Case 2: E. M., a 22 year old colored female, was first seen on January 5, 1951 at the Uni-
versity Hospital Skin Clinic. Admission examination revealed fifteen sharply defined,
atrophic, erythematous plaques 1 to 2 cm. in diameter on both cheeks, forehead, chin and
lower back. Histologic examination confirmed the clinical diagnosis of chronic discoid
lupus erythematosus. Smears from the serum buff y coat were negative for the "L. E. cell."
Urinalyses were negative.
Treatment with chloromycetin was initiated on January 5, 1951 with a dose of 2 gms.,
followed by 0.5 gms. four times daily. Four days after the start of therapy with tbis drug
the white blood count was 4,400. On January 34th, decreased erythema was noted but the
drug was discontinued because of stomatitis, glossitis and leukopenia with neutropenia;
the white blood count was 4,400 and the differential count revealed 37% neutrophiles. On
January 31st, the leukocyte count was 6,700, of which 52% were neutrophiles. Chloro-
mycetin was readministered on February 23rd, but three days later the drug was discon-
tinued again because of recurrent glossitis. The glossitis disappeared a week later, but on
March 7, 1951, the white count had decreased to 4,000 and the neutrophiles count to 37%.
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The leukopenia and neutropenia were still present on the final examination May 23, 1951.
The initial improvement noted when chloromyeetin was first administered was no longer
present on her final examination.
Case 3: L. A., a 30 year old colored female was first seen on January 10, 1951 at the Uni-
versity Hospital Skin Clinic. Examination revealed numerous, sharply demarcated, cry-
thematous, telangiectatie plaques in which there was adherent scaling on the cheeks, nose
and the occipito-parietal areas of the scalp. Histologic examination confirmed the clinical
diagnosis of chronic discoid lupus erythematosus. Serologic tests for syphilis, urinalyses
and smears from the sernm huffy coat were negative. The white blood count was 7,800 with
44% neutrophiles.
On January 12, 1951 treatment with chloromycetin was initiated with a dose of 2 gms.,
followed by doses of 0.5 gms. four times daily. On January 22nd there was a definite decrease
in the erythema of the lesions, but, because of stomatitis and glossitis, administration of
chloromycetin was discontinued. On January 24th, the white blood count had decreased
to 6,000 with 43% neutrophiles, while the stomatitis and glossitis had improved. By January
31st, the mouth and tongue had returned to normal. On February 15th, the leukocyte count
dropped to 4,900 with 27% neutrophiles. Since then, the white blood cell count has varied
from 6,200 to 4,000 and the neutrophiles from 62% to 38%. When last seen, May 15, 1951,
the white blood cell count was 3,500 with 45% neutrophiles. Since March 7, 1951, six weeks
after cessation of chloromycetin therapy, there has been a marked exacerbation of activity
of the lesions.
Case 4: L. S., a 31 year old white female was first seen at the University Hospital Skin
Clinic on July 20, 1948 for an eruption present on the face for four months. A clinical diag-
nosis of chronid discoid lupus erythematosus was made and confirmed by biopsy. Bistrimate
tablets, bismuth subsalicylate in oil intramuscularly and mixed toeopherols by mouth
did not benefit the patient. On January 18, 1951 cbloromycetin therapy was initiated with
a dose of 1 gram, followed by 0.5 gms. every 6 hours. At the start of treatment the white
blood connt was 6,500 with 70% neutrophiles. There was an increase in erythema and edema
of the lesions after 6 days of this regime and chloromycetin was discontinued. The leuko-
eyte connt at this time had dropped to 4,700 with 64% neutrophiles. There was a continued
decrease in the white blood cell count to 4,500 on February 8th, bnt by April 5, 1951 the
hemogram had returned to normal with 8,300 W.B.C. per en. mm. of which 77% were neu-
trophiles.
In addition to the four patients who developed leukopenia while under treat-
ment with ehloromyeetin for chronic discoid lupus erythematosus, ten other
individuals with the same dermatosis were treated with this drug, but did not
develop any hematopoietic abnormality. The summary of treatment and results
in all fourteen patients are presented in Table I. There were seven males and
seven females in the group studied. Four of the seven females developed leuko-
penia while under treatment, but this complication was not noted in any of the
males. In two of the females who developed leukopenia, neutropenia was also
noted. Glossitis and stomatitis were noted in the two patients who developed
neutropenia, but these reactions subsided when the drug was discontinued.
COMMENT
Volini, et al. (5) reported three patients in whom hematologie abnormalities
were encountered during chloromycetin therapy. Two were treated for typhoid
fever and one for acute brucellosis. These three individuals developed a severe,
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but reversible, granulopenia; examination of the bone marrow disclosed granu-
locyte hypoplasia with both erythroid and granulocytic maturation arrest. A
significant fall in the leukocyte count which could be attributed to the diminu-
tion in the number of granulocytes could be demonstrated as early as the sixth
day of therapy. Both marrow and blood changes were reversible and an im-
mediate rise of the white blood count followed discontinuation of therapy. Gill
(6) observed two children who received chloromycetin for salmonella diarrhea,
both of whom developed severe neutropenia within seven and two days, respec-
tively, following initiation of treatment. The hematologic abnormality disap-
peared spontaneously upon discontinuation of the drug. A fatal case of aplastic
anemia following prolonged chloromycetin therapy was reported by Rich, Rit-
terhoff and Hoffman (7). On the other hand, Binagli, Carcassi and Pirastu (8)
studied the behavior of the myelogram and the peripheral blood of two patients
with brucellosis and two normal persons twenty-four hours prior to the admin-
istration of chioramphenicol and twenty-four hours after completion of treat-
ment, and their results showed no evidence of any abnormality of the blood or
bone marrow.
We have administered chloromycetin orally to 500 patients during the course
of our investigation of the value of this drug in dermatoses. Hemograms have
been followed in 92 of these cases, but hematopoietic abnormalities have only
been noted in the four patients discussed in this presentation. The leukopenia
and neutropenia which developed were not dependent on the total dosage of
chloromycetin administered, as we have given larger doses of this drug to many
individuals without encountering any blood abnormality. One patient, a white
male who has chronic discoid lupus erytliematosus (Case 6), and who is still
under treatment with chloromycetin, has received a total dosage of 482 grams
at the time of writing and his hemogram continues to be normal.
It is interesting that in our series the only individuals who developed leuko-
penia while receiving chloromycetin were four out of fourteen patients treated
for chronic discoid lupus erythematosus. Furthermore, this reaction occurred
only in females, though not in all the females treated. The exact relationship of
chronic discoid lupus erythematosus to the systemic variety is still controversial,
but the leukopenia observed in the four females treated for chronic discoid lupus
erythematosus and the predominance of systemic lupus erythematosus (with
leukopenia as a prominent manifestation) in the female may lend credence to
the possible relationship between the chronic discoid and the systemic varieties.
As a nitrobensene derivative, chioromycetin is capable of producing allergic
reactions and in this manner may selectively interfere with myeloid maturation.
This is a possible explanation for the leukopenia and neutropenia encountered
in our cases.
CONCLUSION5
1. Four patients out of fourteen treated for chronic discoid lupus erythema-
tosus with chloromycetin developed leukopenia.
2. This adverse reaction was noted in four out of seven females treated and
in none of the seven males.
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3. The white blood count has returned to normal in two of the patients when
the drug was discontinued; in the other two the leukopenia has remained irre-
versible at the time of writing.
4. The leukopenia was not dependent on the total dosage of chloromycetin
administered.
5. Of five hundred patients treated for various dermatoses with peroral chlo-
romycetin and in eighty-six of which there was an adequate hematologic follow-
up, leukopenia was noted only in the four cases of chronic discoid lupus cry-
thematosus.
6. Five patients showed improvement of the chronic discoid lupus erythcma-
tosus while under chloromycetin treatment, four developed new lesions or showed
increased activity of pre-existing lesions, and five remained unchanged.
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